# Arbital Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/arbital-health

- Industry: Healthcare IT
- Headquarters: San Francisco, US
- Website: www.arbitalhealth.com
- Total disclosed funding: $31M
- Latest round: Series B (Jul 29, 2025)
- Investors on record: 4

## About

Based in California, US, and founded in 2023 by its CEO Brian Overstreet, Arbital Health, Inc. operates as a healthcare technology company that helps companies design and measure outcome-based contracts, serving as a neutral third-party adjudicator. In July 2025, Arbital Health, Inc. raised USD 31 million in series B funding led by new investor Valtruis. Returning investors Transformation Capital, Shaper Ventures, and Healthy Ventures also participated in the round. Arbital Health, Inc. offers a suite of products and services that accelerate the transition to value-based care. Its neutral adjudication utility serves as a tool for bolstering value-based and outcomes-based contracts. By facilitating the design, measurement, and fair adjudication of these contracts. The company plans to utilize the July 2025 funding to enhance payer and provider capabilities, improve value-based care contract management across risk models, grow its actuarial team, and expand its AI platform to support better patient outcomes and financial performance.

## Funding rounds

- Series B, Jul 29, 2025, $31M — Healthy Ventures, Transformation Capital, Valtruis, Shaper Capital

## Investors

- Healthy Ventures (https://capitalatlas.ai/funds/healthy-ventures) — Series B
- Transformation Capital (https://capitalatlas.ai/funds/transformation-capital) — Series B
- Valtruis — Series B
- Shaper Capital — Series B